Szu‐Ting Yang

No ORCID on file · 6 papers in corpus
other 2026
Targeted interleukin 8 (IL-8 or CXCL8) for treating endometriosis
Taiwanese journal of obstetrics & gynecology ·doi:10.1016/j.tjog.2026.06.002
other 2024
Endometriosis: A life-long journey to women
Taiwanese journal of obstetrics & gynecology ·doi:10.1016/j.tjog.2024.05.002
other 2023
Both adjuvant and maintenance therapies are needed in women with symptomatic adenomyosis after uterus-sparing treatment
Taiwanese journal of obstetrics & gynecology ·doi:10.1016/j.tjog.2023.04.001
other 2023
Letter to the editor: Adjuvant or maintenance therapy may be needed in adenomyosis patients after uterus-sparing surgery
International Journal of Gynecology & Obstetrics ·doi:10.1002/ijgo.14678

Peng-Hui Wang, an editorial board member at the International Journal of Gynecology and Obstetrics, had no role in the peer review process or decision to publish this article. The other authors declare that they have no conflicts of interes…

other 2022
Revisit pure laparoscopic surgery for patients with complicated benign diseases
Taiwanese journal of obstetrics & gynecology ·doi:10.1016/j.tjog.2022.03.003
case-report 2021
Endometriosis-associated epithelial ovarian cancer is a more complicated disease than we suspected before
Taiwanese journal of obstetrics & gynecology ·doi:10.1016/j.tjog.2021.09.027

OBJECTIVE: Endometriosis-associated epithelial ovarian cancer (EOC) often includes clear cell carcinoma and endometrioid-type carcinoma. Due to the low incidence of primary mucinous EOC and absence of association between endometriosis and p…